Incoming Quality Inspection (IQI) for Medical Consumables
Kingphar Medical Group New’s 06/10 2026 No results See all results Table of Contents Incoming Quality Inspection (IQI) for Medical Consumables: Complete Guide Procurement Quality ·
ISO 13485 certified. CE, FDA & SFDA registered. Trusted by distributors in 60+ countries.
ISO, CE, FDA certificates and product specification sheets.
Keywords:Medical trade
From May 10-11, 2025, China and the United States held high-level economic and trade talks in Geneva, Switzerland, achieving significant results. Chinese Vice Premier He Lifeng engaged in candid and in-depth dialogue with US Treasury Secretary Bessen and Trade Representative Greer, leading to the release of a “Joint Statement on China-US Geneva Economic and Trade Talks” on May 12.
Previously, in April 2025, the US government unilaterally imposed “reciprocal tariffs” on Chinese goods, gradually increasing rates from 34% to 125%, which seriously damaged bilateral economic relations and the international trade order. China responded with firm countermeasures.
These talks represent an important step in resolving differences through equal dialogue, creating conditions for further bridging gaps and deepening cooperation. The tariff reduction measures meet the expectations of producers and consumers in both countries and benefit global economic stability.
There is hope that the US will continue to work with China, completely correct unilateral tariff practices, strengthen mutually beneficial cooperation, maintain healthy development of China-US economic and trade relations, and inject more certainty and stability into the world economy.
From May 10 to 11, local time, He Lifeng, the Chinese leader of China-US economic and trade talks and Vice Premier of the State Council, held high-level economic and trade talks between China and the United States with the US leaders, US Treasury Secretary Bensont and Trade Representative Greer in Geneva, Switzerland. The two sides had candid, in-depth and constructive communication on the implementation of the important consensus reached by the Chinese and US heads of state on January 17 this year, and reached a series of important consensus in the economic and trade fields. At 9:00 am on May 12, local time, the two sides issued the “Joint Statement of the China-US Geneva Economic and Trade Talks”. The spokesperson of the Ministry of Commerce made a statement on this.
Since April 2025, the US government has imposed so-called “reciprocal tariffs” on China on the basis of the previous unilateral tariff increase, and China has resolutely and legitimately countered. Subsequently, the US side successively upgraded its tariff measures, raising the “reciprocal tariff” rate on China from 34% in the first round to 84% and 125% successively. The high tariffs of the United States seriously damaged the normal economic and trade exchanges between the two sides and seriously undermined the international economic and trade order. The joint statement reached during the talks is an important step for the two sides to resolve differences through equal dialogue and consultation, laying the foundation and creating conditions for further bridging differences and deepening cooperation.
The two sides reached a number of positive consensuses in the joint statement. The two sides recognize the importance of bilateral economic and trade relations to the economies of the two countries and the world, and recognize the importance of sustainable, long-term and mutually beneficial bilateral economic and trade relations. In the spirit of mutual openness, continuous communication, cooperation and mutual respect, they will continue to advance relevant work. The two sides agreed to jointly take the following measures:
The United States pledged to cancel a total of 91% of tariffs imposed on Chinese goods in accordance with Executive Order No. 14259 of April 8, 2025 and Executive Order No. 14266 of April 9, 2025, and to amend the 34% reciprocal tariffs imposed on Chinese goods in Executive Order No. 14257 of April 2, 2025, of which 24% of tariffs will be suspended for 90 days and the remaining 10% of tariffs will be retained. Accordingly, China canceled a total of 91% of the counter-tariffs imposed on US goods; in response to the 34% counter-tariffs of the US reciprocal tariffs, 24% of the tariffs were suspended for 90 days, and the remaining 10% of the tariffs were retained. China also suspended or canceled non-tariff countermeasures against the United States accordingly.
The two sides agreed to establish a Sino-US economic and trade consultation mechanism to maintain close communication on their respective concerns in the economic and trade fields and conduct further consultations. The Chinese representative was Vice Premier He Lifeng, and the US representative was Treasury Secretary Bessant and Trade Representative Greer. The two sides will conduct consultations regularly or irregularly in China and the United States, or in agreed third countries. As needed, the two sides may conduct working-level consultations on relevant economic and trade issues.
This Sino-US high-level economic and trade talks made substantial progress and significantly reduced the level of bilateral tariffs. The US canceled a total of 91% of the additional tariffs, and China correspondingly canceled 91% of the counter-tariffs; the US suspended the implementation of 24% of the “reciprocal tariffs”, and China also suspended the implementation of 24% of the counter-tariffs accordingly. This move is in line with the expectations of producers and consumers in both countries, and is in the interests of both countries and the common interests of the world. We hope that the US will build on this meeting and continue to work with China to meet each other halfway, thoroughly correct the wrong practice of unilateral tariff increases, continuously strengthen mutually beneficial cooperation, maintain the healthy, stable and sustainable development of China-US economic and trade relations, and jointly inject more certainty and stability into the world economy.
Kingphar Medical Group New’s 06/10 2026 No results See all results Table of Contents Incoming Quality Inspection (IQI) for Medical Consumables: Complete Guide Procurement Quality ·
Kingphar Medical Group New’s 06/10 2026 No results See all results Table of Contents Incoterms for Medical Supplies: FOB vs CIF vs DDP Explained (2026) Procurement
Kingphar Medical Group New’s 21/9 2026 No results See all results Table of Contents Inventory Management · Procurement Guide Medical ConsumablesShelf Life & ExpiryManagement Guide Shelf
Kingphar Medical Group New’s 31/8 2026 No results See all results Table of Contents Procurement Guide · Tender Writing How to Write Medical ConsumableTender SpecificationsThat Win
Kingphar Medical Group New’s 18/8 2026 No results See all results Table of Contents Procurement Guide · Import & Customs Medical ConsumablesImport Documentation:The Complete Checklist A
Kingphar Medical Group New’s 7/8 2026 No results See all results Table of Contents Procurement Guide · Import & Customs Medical Consumables HS Codes:Classification & ImportDuty
This website uses cookies
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.
Cookies are small text files that can be used by websites to make a user's experience more efficient.
The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This means that cookies which are categorized as necessary, are processed based on GDPR Art. 6 (1) (f). All other cookies, meaning those from the categories preferences and marketing, are processed based on GDPR Art. 6 (1) (a) GDPR.
This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
You can at any time change or withdraw your consent from the Cookie Declaration on our website.
Learn more about who we are, how you can contact us and how we process personal data in our Privacy Policy.
Please state your consent ID and date when you contact us regarding your consent.
